Immunization with SsEno fails to protect mice against challenge with Streptococcus suis serotype 2: RESEARCH LETTER

FEMS Microbiology Letters

Volumn 294, Issue 1, 2009, Pages 82-88

  Esgleas, Miriam ^a   Dominguez Punaro, Maria De La Cruz ^a   Li, Yuanyi ^a   Harel, Josée ^a   Dubreuil, J Daniel ^a   Gottschalk, Marcelo ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Protection assay; SsEno; Streptococcus suis

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; QUIL A; STREPTOCOCCUS SUIS ENOLASE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROL GROUP; CONTROLLED STUDY; CONVALESCENCE; FEMALE; IMMUNOGENICITY; IN VITRO STUDY; MORTALITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PHAGOCYTE; PRIORITY JOURNAL; PROTECTION; RABBIT; SERUM; STREPTOCOCCUS SUIS; STREPTOCOCCUS SUIS SEROTYPE 2; SWINE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MACROPHAGES; MENINGITIS, BACTERIAL; MICE; PHOSPHOPYRUVATE HYDRATASE; RABBITS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS SUIS; SURVIVAL ANALYSIS; SWINE;

MUS; ORYCTOLAGUS CUNICULUS; STREPTOCOCCUS SUIS; SUIDAE;

EID: 63849184097     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2009.01551.x     Document Type: Article

References (34)

1. Baums CG, Kaim U, Fulde M, Ramachandran G, Goethe R Valentin-Weigand P (2006) Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infect Immun 74 : 6154 6162.
2. Berthelot-Herault F, Gottschalk M, Morvan H Kobisch M (2005) Dilemma of virulence of Streptococcus suis: Canadian isolate 89-1591 characterized as a virulent strain using a standardized experimental model in pigs. Can J Vet Res 69 : 236 240.
3. Busque P, Higgins R, Caya F Quessy S (1997) Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain. Can J Vet Res 61 : 275 279.
4. Chabot-Roy G, Willson P, Segura M, Lacouture S Gottschalk M (2006) Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb Pathogenesis 41 : 21 32.
5. Charland N, Jacques M, Lacouture S Gottschalk M (1997) Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2. Microbiology 143 : 3607 3614.
6. Charland N, Nizet V, Rubens CE, Kim KS, Lacouture S Gottschalk M (2000) Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun 68 : 637 643.
7. Dominguez-Punaro MC, Segura M, Plante MM, Lacouture S, Rivest S Gottschalk M (2007) Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J Immunol 179 : 1842 1854.
8. Ehinger S, Schubert WD, Bergmann S, Hammerschmidt S Heinz DW (2004) Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites. J Mol Biol 343 : 997 1005.
9. Esgleas M, Li Y, Hancock MA, Harel J, Dubreuil JD Gottschalk M (2008) Isolation and characterization of a-enolase, a new fibronectin-binding protein from Streptococcus suis. Microbiology 154 : 2668 2679.
10. Gottschalk M Segura M (2000) The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet Microbiol 76 : 259 272.
11. Gottschalk M, Segura M Xu J (2007) Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim Health Res Rev 8 : 29 45.
12. Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R Decostere A (2004) Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet Microbiol 100 : 255 268.
13. Halbur P, Thanawongnuwech R, Brown G, Kinyon J, Roth J, Thacker E Thacker B (2000) Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs. J Clin Microbiol 38 : 1156 1160.
14. Higgins R Gottschalk M (2005) Streptococcal diseases. Diseases of Swine (Straw BE, D'Allaire S, Mengeling WL Taylor DJ, eds), pp. 769 783. Iowa State University Press, Ames, IA.
15. Jacobs AA, van den Berg AJ Loeffen PL (1996) Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis. Vet Rec 139 : 225 228.
16. Jing HB, Yuan J, Wang J et al 2008) Proteome analysis of Streptococcus suis serotype 2. Proteomics 8 : 333 349.
17. Lancefield RC (1957) Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med 106 : 525 544.
18. Lapointe L, D'Allaire S, Lebrun A, Lacouture S Gottschalk M (2002) Antibody response to an autogenous vaccine and serologic profile for Streptococcus suis capsular type 1/2. Can J Vet Res 66 : 8 14.
19. Li Y, Martinez G, Gottschalk M et al 2006) Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs. Infect Immun 74 : 305 312.
20. Li Y, Gottschalk M, Esgleas M, Lacouture S, Dubreuil JD, Willson P Harel J (2007) Immunization with recombinant Sao protein confers protection against Streptococcus suis infection. Clin Vaccine Immunol 14 : 937 943.
21. Lowry OH, Rosebrough NJ, Farr AL Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193 : 267 275.
22. Lun ZR, Wang QP, Chen XG, Li AX Zhu XQ (2007) Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect Dis 7 : 201 209.
23. Madsen LW, Svensmark B, Elvestad K, Aalbaek B Jensen HE (2002) Streptococcus suis serotype 2 infection in pigs: new diagnostic and pathogenetic aspects. J Comp Pathol 126 : 57 65.
24. Montagnoli C, Sandini S, Bacci A, Romani L La Valle R (2004) Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med Mycol 42 : 319 324.
25. Pal-Bhowmick I, Mehta M, Coppens I, Sharma S Jarori GK (2007) Protective properties and surface localization of Plasmodium falciparum enolase. Infect Immun 75 : 5500 5508.
26. Pancholi V Fischetti VA (1998) alpha -enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 273 : 14503 14515.
27. Rennermalm A, Li YH, Bohaufs L, Jarstrand C, Brauner A, Brennan FR Flock JI (2001) Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 19 : 3376 3383.
28. Shah P Swiatlo E (2006) Immunization with polyamine transport protein PotPD protects mice against systemic infection with Streptococcus pneumoniae. Infect Immun 74 : 5888 5892.
29. Smith HE, Damman M, van der Velde J, Wagenaar F, Wisselink HJ, Stockhofe-Zurwieden N Smits MA (1999) Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect Immun 67 : 1750 1756.
30. Takamatsu D, Osaki M, Tharavichitkul P, Takai S Sekizaki T (2008) Allelic variation and prevalence of serum opacity factor among the Streptococcus suis population. J Med Microbiol 57 : 488 494.
31. Terrier B, Degand N, Guilpain P, Servettaz A, Guillevin L Mouthon L (2007) Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun Rev 6 : 176 182.
32. Vanier G, Segura M Gottschalk M (2007) Characterization of the invasion of porcine endothelial cells by Streptococcus suis serotype 2. Can J Vet Res 71 : 81 89.
33. Wisselink HJ, Vecht U, Stockhofe-Zurwieden N Smith HE (2001) Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet Rec 148 : 473 477.
34. Wizemann TM, Adamou JE Langermann S (1999) Adhesins as targets for vaccine development. Emerg Infect Dis 5 : 395 403.